<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p46" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_46{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_46{left:808px;bottom:1132px;letter-spacing:-0.08px;}
#t3_46{left:162px;bottom:1085px;letter-spacing:0.11px;word-spacing:3.16px;}
#t4_46{left:162px;bottom:1067px;letter-spacing:0.11px;word-spacing:-0.61px;}
#t5_46{left:819px;bottom:1067px;}
#t6_46{left:162px;bottom:1050px;letter-spacing:0.12px;word-spacing:3.54px;}
#t7_46{left:413px;bottom:1050px;}
#t8_46{left:424px;bottom:1050px;letter-spacing:0.12px;word-spacing:3.54px;}
#t9_46{left:162px;bottom:1032px;letter-spacing:0.1px;}
#ta_46{left:236px;bottom:1032px;letter-spacing:0.11px;word-spacing:0.38px;}
#tb_46{left:162px;bottom:1015px;letter-spacing:0.11px;word-spacing:1.5px;}
#tc_46{left:162px;bottom:997px;letter-spacing:0.11px;word-spacing:0.51px;}
#td_46{left:162px;bottom:979px;letter-spacing:0.1px;word-spacing:0.03px;}
#te_46{left:141px;bottom:919px;letter-spacing:0.14px;}
#tf_46{left:162px;bottom:897px;letter-spacing:0.14px;}
#tg_46{left:162px;bottom:860px;letter-spacing:0.1px;word-spacing:-0.85px;}
#th_46{left:262px;bottom:867px;letter-spacing:-0.03px;}
#ti_46{left:275px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.82px;}
#tj_46{left:322px;bottom:867px;letter-spacing:-0.03px;}
#tk_46{left:334px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.84px;}
#tl_46{left:441px;bottom:867px;}
#tm_46{left:446px;bottom:860px;letter-spacing:0.1px;word-spacing:-0.84px;}
#tn_46{left:541px;bottom:867px;}
#to_46{left:546px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.83px;}
#tp_46{left:659px;bottom:867px;}
#tq_46{left:664px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.83px;}
#tr_46{left:772px;bottom:867px;}
#ts_46{left:777px;bottom:860px;letter-spacing:0.08px;word-spacing:-0.83px;}
#tt_46{left:162px;bottom:842px;letter-spacing:0.12px;word-spacing:1.13px;}
#tu_46{left:228px;bottom:850px;}
#tv_46{left:233px;bottom:842px;letter-spacing:0.12px;word-spacing:1.12px;}
#tw_46{left:332px;bottom:850px;}
#tx_46{left:336px;bottom:842px;letter-spacing:0.11px;word-spacing:1.12px;}
#ty_46{left:443px;bottom:850px;}
#tz_46{left:448px;bottom:842px;letter-spacing:0.11px;word-spacing:1.11px;}
#t10_46{left:558px;bottom:850px;}
#t11_46{left:563px;bottom:842px;letter-spacing:0.12px;word-spacing:1.12px;}
#t12_46{left:693px;bottom:850px;}
#t13_46{left:698px;bottom:842px;letter-spacing:0.11px;word-spacing:1.12px;}
#t14_46{left:814px;bottom:850px;}
#t15_46{left:819px;bottom:842px;}
#t16_46{left:162px;bottom:824px;letter-spacing:0.13px;word-spacing:0.04px;}
#t17_46{left:293px;bottom:832px;}
#t18_46{left:162px;bottom:815px;}
#t19_46{left:167px;bottom:807px;letter-spacing:0.11px;word-spacing:1.35px;}
#t1a_46{left:728px;bottom:815px;}
#t1b_46{left:733px;bottom:807px;letter-spacing:0.11px;word-spacing:1.36px;}
#t1c_46{left:162px;bottom:789px;letter-spacing:0.11px;word-spacing:1.51px;}
#t1d_46{left:590px;bottom:797px;}
#t1e_46{left:595px;bottom:789px;letter-spacing:0.11px;word-spacing:1.51px;}
#t1f_46{left:162px;bottom:772px;letter-spacing:0.1px;word-spacing:-0.65px;}
#t1g_46{left:507px;bottom:779px;}
#t1h_46{left:512px;bottom:772px;letter-spacing:0.11px;word-spacing:-0.65px;}
#t1i_46{left:162px;bottom:754px;letter-spacing:0.1px;word-spacing:0.03px;}
#t1j_46{left:162px;bottom:719px;letter-spacing:0.11px;word-spacing:2.67px;}
#t1k_46{left:162px;bottom:701px;letter-spacing:0.12px;word-spacing:4.82px;}
#t1l_46{left:162px;bottom:684px;letter-spacing:0.1px;word-spacing:-0.45px;}
#t1m_46{left:162px;bottom:666px;letter-spacing:0.11px;word-spacing:1.16px;}
#t1n_46{left:162px;bottom:649px;letter-spacing:0.13px;word-spacing:6.66px;}
#t1o_46{left:162px;bottom:631px;letter-spacing:0.11px;word-spacing:-0.52px;}
#t1p_46{left:162px;bottom:613px;letter-spacing:0.11px;word-spacing:0.03px;}
#t1q_46{left:162px;bottom:596px;letter-spacing:0.12px;word-spacing:2.44px;}
#t1r_46{left:162px;bottom:578px;letter-spacing:0.11px;word-spacing:-0.07px;}
#t1s_46{left:162px;bottom:561px;letter-spacing:0.12px;word-spacing:0.67px;}
#t1t_46{left:162px;bottom:543px;letter-spacing:0.11px;word-spacing:0.8px;}
#t1u_46{left:162px;bottom:525px;letter-spacing:0.11px;word-spacing:-0.3px;}
#t1v_46{left:162px;bottom:508px;letter-spacing:0.12px;word-spacing:0.13px;}
#t1w_46{left:162px;bottom:490px;letter-spacing:0.1px;word-spacing:-0.74px;}
#t1x_46{left:162px;bottom:473px;letter-spacing:0.12px;word-spacing:1.09px;}
#t1y_46{left:162px;bottom:455px;letter-spacing:0.1px;word-spacing:0.37px;}
#t1z_46{left:162px;bottom:438px;letter-spacing:0.12px;word-spacing:2.64px;}
#t20_46{left:162px;bottom:420px;letter-spacing:0.12px;word-spacing:5.57px;}
#t21_46{left:162px;bottom:403px;letter-spacing:0.1px;word-spacing:0.03px;}
#t22_46{left:141px;bottom:342px;letter-spacing:0.14px;}
#t23_46{left:162px;bottom:321px;letter-spacing:0.16px;}
#t24_46{left:162px;bottom:282px;letter-spacing:0.12px;word-spacing:0.02px;}
#t25_46{left:271px;bottom:290px;}
#t26_46{left:276px;bottom:287px;}
#t27_46{left:283px;bottom:282px;letter-spacing:0.12px;word-spacing:0.03px;}
#t28_46{left:431px;bottom:290px;}
#t29_46{left:436px;bottom:287px;}
#t2a_46{left:444px;bottom:282px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2b_46{left:559px;bottom:290px;}
#t2c_46{left:564px;bottom:282px;}
#t2d_46{left:572px;bottom:282px;letter-spacing:0.14px;word-spacing:0.03px;}
#t2e_46{left:713px;bottom:290px;}
#t2f_46{left:162px;bottom:272px;}
#t2g_46{left:167px;bottom:264px;letter-spacing:0.1px;word-spacing:0.02px;}
#t2h_46{left:335px;bottom:272px;}
#t2i_46{left:340px;bottom:264px;letter-spacing:0.1px;word-spacing:0.03px;}
#t2j_46{left:162px;bottom:247px;}
#t2k_46{left:170px;bottom:242px;letter-spacing:0.1px;word-spacing:0.02px;}
#t2l_46{left:162px;bottom:207px;letter-spacing:0.14px;}
#t2m_46{left:253px;bottom:207px;letter-spacing:0.11px;word-spacing:0.82px;}
#t2n_46{left:162px;bottom:190px;letter-spacing:0.12px;word-spacing:2.29px;}
#t2o_46{left:162px;bottom:172px;letter-spacing:0.11px;word-spacing:0.61px;}
#t2p_46{left:162px;bottom:154px;letter-spacing:0.1px;word-spacing:0.03px;}
#t2q_46{left:162px;bottom:137px;letter-spacing:0.13px;word-spacing:4.89px;}
#t2r_46{left:336px;bottom:137px;letter-spacing:0.12px;word-spacing:4.89px;}
#t2s_46{left:162px;bottom:119px;letter-spacing:0.12px;word-spacing:1.17px;}
#t2t_46{left:162px;bottom:102px;letter-spacing:0.11px;word-spacing:0.61px;}
#t2u_46{left:162px;bottom:84px;letter-spacing:0.1px;word-spacing:0.02px;}

.s0_46{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_46{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_46{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s3_46{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s4_46{font-size:10px;font-family:TimesNewRomanPSMT_87;color:#000;}
.s5_46{font-size:10px;font-family:TimesNewRomanPS-BoldMT_8j;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts46" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_8j;
	src: url("fonts/TimesNewRomanPS-BoldMT_8j.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_87;
	src: url("fonts/TimesNewRomanPSMT_87.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg46Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg46" style="-webkit-user-select: none;"><object width="935" height="1210" data="46/46.svg" type="image/svg+xml" id="pdf46" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_46" class="t s0_46">Brain: Chemistry to Cognition </span><span id="t2_46" class="t s1_46">38 </span>
<span id="t3_46" class="t s0_46">damage. Furthermore, microhemorrhages, a potential safety liability seen in clinical stage drugs, were </span>
<span id="t4_46" class="t s0_46">reduced. Here, we show that Gal-3 promotes oligomerization of Aβ and other pathogenic factors, and TB006</span><span id="t5_46" class="t s2_46">, </span>
<span id="t6_46" class="t s0_46">a monoclonal antibody targeting Gal-3</span><span id="t7_46" class="t s2_46">, </span><span id="t8_46" class="t s0_46">acts as a possible treatment for AD by degrading neurotoxic </span>
<span id="t9_46" class="t s0_46">oligomers. </span><span id="ta_46" class="t s0_46">Pre-clinical studies show that TB006 is an efficacious therapeutic entity through degradation of </span>
<span id="tb_46" class="t s0_46">toxic oligomers and blocking or even reversing AD progression. Clinically, TB006 has shown a superior </span>
<span id="tc_46" class="t s0_46">safety profile without any drug-related adverse events in healthy volunteer trial. Promising efficacious data </span>
<span id="td_46" class="t s0_46">are expected from the ongoing phase II AD trial. </span>
<span id="te_46" class="t s3_46">S15.3. Neuroprotective strategies to prevent neuroinflammation and cognitive </span>
<span id="tf_46" class="t s3_46">dysfunction in cranial radiation-induced brain injury </span>
<span id="tg_46" class="t s0_46">Robert P. Krattli </span>
<span id="th_46" class="t s4_46">1,* </span>
<span id="ti_46" class="t s0_46">, An Do </span>
<span id="tj_46" class="t s4_46">1,* </span>
<span id="tk_46" class="t s0_46">, Sanad El-Khatib </span>
<span id="tl_46" class="t s4_46">1 </span>
<span id="tm_46" class="t s0_46">, Leila Alikhani </span>
<span id="tn_46" class="t s4_46">1 </span>
<span id="to_46" class="t s0_46">, Mineh Markarian </span>
<span id="tp_46" class="t s4_46">1 </span>
<span id="tq_46" class="t s0_46">, Arya R. Vagadia </span>
<span id="tr_46" class="t s4_46">1 </span>
<span id="ts_46" class="t s0_46">, Manal </span>
<span id="tt_46" class="t s0_46">T. Usmani </span>
<span id="tu_46" class="t s4_46">1 </span>
<span id="tv_46" class="t s0_46">, Shreya Madan </span>
<span id="tw_46" class="t s4_46">1 </span>
<span id="tx_46" class="t s0_46">, Janet E. Baulch </span>
<span id="ty_46" class="t s4_46">2 </span>
<span id="tz_46" class="t s0_46">, Richard J. Clark </span>
<span id="t10_46" class="t s4_46">3 </span>
<span id="t11_46" class="t s0_46">, Trent M. Woodruff </span>
<span id="t12_46" class="t s4_46">3 </span>
<span id="t13_46" class="t s0_46">, Andrea J. Tenner </span>
<span id="t14_46" class="t s4_46">4 </span>
<span id="t15_46" class="t s0_46">, </span>
<span id="t16_46" class="t s2_46">Munjal M. Acharya </span>
<span id="t17_46" class="t s5_46">1 </span>
<span id="t18_46" class="t s4_46">1 </span>
<span id="t19_46" class="t s0_46">Department of Anatomy &amp; Neurobiology, University of California Irvine, United States; </span>
<span id="t1a_46" class="t s4_46">2 </span>
<span id="t1b_46" class="t s0_46">Department of </span>
<span id="t1c_46" class="t s0_46">Radiation Oncology, University of California Irvine, United States; </span>
<span id="t1d_46" class="t s4_46">3 </span>
<span id="t1e_46" class="t s0_46">School of Biomedical Sciences, The </span>
<span id="t1f_46" class="t s0_46">University of Queensland, St Lucia, Brisbane, Australia; </span>
<span id="t1g_46" class="t s4_46">4 </span>
<span id="t1h_46" class="t s0_46">Department of Molecular Biology &amp; Biochemistry, </span>
<span id="t1i_46" class="t s0_46">University of California Irvine, United States; *Contributed equally </span>
<span id="t1j_46" class="t s0_46">Cranial radiation therapy (CRT) for brain cancers leads to long-term, irreversible impacts on cognitive </span>
<span id="t1k_46" class="t s0_46">function. We have shown that CRT-induced cognitive deficits (RICD) are linked with (i) elevated </span>
<span id="t1l_46" class="t s0_46">microgliosis, astrogliosis, (ii) aberrant CNS complement cascade activation, and (iii) excessive synaptic loss. </span>
<span id="t1m_46" class="t s0_46">CNS complement system mediates reactive gliosis and regulates synaptic pruning, which is detrimental if </span>
<span id="t1n_46" class="t s0_46">dysregulated. Complement components also promote glioma proliferation and invasiveness. Thus, </span>
<span id="t1o_46" class="t s0_46">complement cascade inhibition would be beneficial against RICD and glioma. We used gene knockdown and </span>
<span id="t1p_46" class="t s0_46">pharmacologic approaches: microglia-selective C1q-KO, C5aR1-KO, and an orally active, BBB-permeable, </span>
<span id="t1q_46" class="t s0_46">C5aR1 antagonist (PMX205) to reverse RICD. C1q-KO mice lack C1q expression in the CNS without </span>
<span id="t1r_46" class="t s0_46">affecting circulating C1q, thus designed to determine CNS-specific impact of C1q-KO. Adult WT C57 mice </span>
<span id="t1s_46" class="t s0_46">received 9 Gy CRT and PMX205 treatment in drinking water for 1-month. Adult C1q-KO and C5aR1-KO </span>
<span id="t1t_46" class="t s0_46">mice received CRT. Cognitive function, tissue, and cellular studies were carried out one-month post-CRT. </span>
<span id="t1u_46" class="t s0_46">CRT significantly impaired cognitive function compared to the irradiated C1q-KO, C5aR1-KO, or irradiated </span>
<span id="t1v_46" class="t s0_46">WT mice+PMX205 on the frontal cortex and hippocampal-dependent behavior tasks. C1q-KO, C5aR1-KO, </span>
<span id="t1w_46" class="t s0_46">and PMX205 reduced microglial activation and synaptic loss in the irradiated brains. Importantly, either C1q- </span>
<span id="t1x_46" class="t s0_46">KO, C5aR1-KO or PMX205 treatment to the syngeneic, orthotopic astrocytoma and glioblastoma-bearing </span>
<span id="t1y_46" class="t s0_46">mice did not interfere with the therapeutic efficacy of CRT in killing tumor in vivo. In summary, inhibition </span>
<span id="t1z_46" class="t s0_46">of CNS complement signaling is neuroprotective from toxic, overzealous inflammatory effects of CRT </span>
<span id="t20_46" class="t s0_46">without interfering with the therapeutic efficacy for glioma and thereby supports the translational </span>
<span id="t21_46" class="t s0_46">applicability of this novel approach. </span>
<span id="t22_46" class="t s3_46">S15.4. Sex-specific locus coeruleus dysfunction expedites disease progression in </span>
<span id="t23_46" class="t s3_46">APP/PS1 mice </span>
<span id="t24_46" class="t s0_46">Srishti Kushwaha </span>
<span id="t25_46" class="t s4_46">1</span><span id="t26_46" class="t s0_46">† </span>
<span id="t27_46" class="t s0_46">, Rupsa Roy Choudhury </span>
<span id="t28_46" class="t s4_46">1</span><span id="t29_46" class="t s0_46">† </span>
<span id="t2a_46" class="t s0_46">, Jyotirmoy Biswal </span>
<span id="t2b_46" class="t s4_46">2 </span>
<span id="t2c_46" class="t s0_46">, </span><span id="t2d_46" class="t s2_46">Smitha Karunakaran </span>
<span id="t2e_46" class="t s5_46">1 </span>
<span id="t2f_46" class="t s4_46">1 </span>
<span id="t2g_46" class="t s0_46">Centre for Brain Research, </span>
<span id="t2h_46" class="t s4_46">2 </span>
<span id="t2i_46" class="t s0_46">Indian Institute of Science, Bangalore. </span>
<span id="t2j_46" class="t s0_46">† </span>
<span id="t2k_46" class="t s0_46">These authors contributed equally </span>
<span id="t2l_46" class="t s2_46">Background: </span><span id="t2m_46" class="t s0_46">Alzheimer’s disease (AD) is more prevalent in women than men above the age of 65. Early </span>
<span id="t2n_46" class="t s0_46">symptoms include sleep disturbances and neuropsychiatric symptoms, and involves a brainstem nucleus </span>
<span id="t2o_46" class="t s0_46">called locus coeruleus (LC). However, fundamental biology of LC, and how they may drive the prodromal </span>
<span id="t2p_46" class="t s0_46">stages of AD is not known. </span>
<span id="t2q_46" class="t s2_46">Materials and methods: </span><span id="t2r_46" class="t s0_46">Stereological assessment of LC neurons, and LC terminal density in the </span>
<span id="t2s_46" class="t s0_46">hippocampus were evaluated in the APP/PS1 mice using ImageJ. LC was stimulated using environmental </span>
<span id="t2t_46" class="t s0_46">enrichment (EE), and structural changes in hippocampus astrocytes were studied using ImageJ. Evans blue </span>
<span id="t2u_46" class="t s0_46">tail vein injections were performed to account for blood brain barrier breach. </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
